DE69331003D1 - Kristalle von derivaten von chinozon carbonsäure-hydraten - Google Patents

Kristalle von derivaten von chinozon carbonsäure-hydraten

Info

Publication number
DE69331003D1
DE69331003D1 DE69331003T DE69331003T DE69331003D1 DE 69331003 D1 DE69331003 D1 DE 69331003D1 DE 69331003 T DE69331003 T DE 69331003T DE 69331003 T DE69331003 T DE 69331003T DE 69331003 D1 DE69331003 D1 DE 69331003D1
Authority
DE
Germany
Prior art keywords
chinozone
crystals
derivatives
carbonic acid
acid hydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331003T
Other languages
English (en)
Other versions
DE69331003T2 (de
Inventor
Hiroyuki Nagano
Nobuyuki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69331003D1 publication Critical patent/DE69331003D1/de
Publication of DE69331003T2 publication Critical patent/DE69331003T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69331003T 1992-01-31 1993-01-29 Kristalle von derivaten von chinozon carbonsäure-hydraten Expired - Fee Related DE69331003T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1654592 1992-01-31
PCT/JP1993/000109 WO1993015070A1 (en) 1992-01-31 1993-01-29 Crystal of quinolonecarboxylic acid derivative hydrate

Publications (2)

Publication Number Publication Date
DE69331003D1 true DE69331003D1 (de) 2001-11-29
DE69331003T2 DE69331003T2 (de) 2002-06-20

Family

ID=11919237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331003T Expired - Fee Related DE69331003T2 (de) 1992-01-31 1993-01-29 Kristalle von derivaten von chinozon carbonsäure-hydraten

Country Status (8)

Country Link
US (1) US5597923A (de)
EP (1) EP0629621B1 (de)
KR (1) KR100228572B1 (de)
AT (1) ATE207479T1 (de)
CA (1) CA2128601C (de)
DE (1) DE69331003T2 (de)
ES (1) ES2167329T3 (de)
WO (1) WO1993015070A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236852B1 (ko) * 1992-10-09 2000-03-02 나가야마 오사무 플루오로 퀴놀린 유도체
CA2201735A1 (en) * 1994-11-18 1996-05-30 The Upjohn Company A new physically stable solid form of a fluoroquinolone
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
US7423153B2 (en) 2002-05-10 2008-09-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of gatifloxacin
EP1645274A1 (de) * 2002-05-10 2006-04-12 Teva Pharmaceutical Industries Ltd. Verfahren zur Herstellung von Gatifloxacinform Omega
JP2005534633A (ja) * 2002-05-10 2005-11-17 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規結晶形
US7411067B2 (en) 2002-06-14 2008-08-12 Teva Pharmaceutical Industries Ltd Crystalline forms of gatifloxacin
EP1545530A1 (de) 2002-08-06 2005-06-29 Teva Pharmaceutical Industries Limited Neue kristalline formen von gatifloxacin
US20060264635A1 (en) * 2003-08-05 2006-11-23 Chava Satyanarayana Process for the preparation of moxifloxacin hydrochloride
WO2005118546A1 (en) * 2004-06-04 2005-12-15 Matrix Laboratories Ltd Novel crystalline forms of gatifloxacin
US7594151B2 (en) * 2004-06-18 2009-09-22 Qualcomm, Incorporated Reverse link power control in an orthogonal system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
JPS6490184A (en) * 1987-09-30 1989-04-06 Sankyo Co Pyridonecarboxylic acids
CA1340285C (en) * 1988-05-19 1998-12-22 Hiroyuki Nagano Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent

Also Published As

Publication number Publication date
CA2128601C (en) 2003-07-15
US5597923A (en) 1997-01-28
CA2128601A1 (en) 1993-08-05
ES2167329T3 (es) 2002-05-16
EP0629621A4 (de) 1995-02-01
EP0629621A1 (de) 1994-12-21
DE69331003T2 (de) 2002-06-20
WO1993015070A1 (en) 1993-08-05
KR950700281A (ko) 1995-01-16
KR100228572B1 (ko) 1999-11-01
ATE207479T1 (de) 2001-11-15
EP0629621B1 (de) 2001-10-24

Similar Documents

Publication Publication Date Title
ATE176474T1 (de) Cyclohexan-derivate, sie enthaltende zusammensetzungen und ihre verwendung
NZ234327A (en) Quinazoline derivatives and pharmaceutical compositions
ID1018B (id) N-tersier-butil-dekahidro-2(3-amino-2-hidroksi-4-fenil-butil) isokinolin-3-karboksamida dan turunan-turunan asparaginil darinya
DE69331003D1 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
KR870700620A (ko) 신규 약리학적 화합물
DE3777735D1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
NO931482L (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
DE3882895T2 (de) Imid-Derivate, ihre Herstellung und Verwendung.
DE3782347D1 (de) Hetaryl-oxy-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
SE7901493L (sv) Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel
ATE176230T1 (de) Spiropyran-derivate mit photochromischen eigenschaften
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
DE59404557D1 (de) Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE3877036D1 (de) Biologisch aktive verbindungen.
ATE123497T1 (de) Substituierte pyridin-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee